COVID-19

New research identifies two substances secreted by immune cells as contributors to myocarditis among mRNA COVID-19 vaccine recipients – and suggests a strategy for mitigating this effect.

Stanford economist Nicholas Bloom examines why some downtowns may not return to normal and what this could mean for the future.

Part of the rise in employment among Americans with disabilities can be attributed to more opportunities to work from home, says economics Professor Nicholas Bloom.

Paxlovid, while effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in a single-center study.

Stanford researchers revealed the replication process of SARS-CoV-2 using super-resolution microscopy, which may have applications for drug development.

More than 1,000 lawsuits challenged community mitigation efforts and public health orders imposed during the COVID-19 pandemic. While most of those plaintiffs lost their cases, a new study looks at the 112 that were successful.

A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.

A new study by Stanford sociologist Florencia Torche shows the powerful impact of soon-to-be-moms getting the COVID-19 vaccine during pregnancy: It’s good for mother and baby.

Researchers have developed methods for using wastewater to track the levels of various respiratory viruses in a population. This can provide real-time information about virus circulation in a community.